Back
Madrigal Pharmaceuticals Vs. Gilead Sciences Industry Stock Comparison
Buy
77
MDGL
Madrigal Pharmaceuticals
Last Price:
279.95
Seasonality Move:
1.42%
Sell
42
GILD
Gilead Sciences
Last Price:
68.59
Seasonality Move:
9.98%
Buy
77
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $280.16. The Score for MDGL is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Gilead Sciences (GILD)
is a Sell
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $68.61. The Score for GILD is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- GILD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $280.16
The current trend is moderately bullish and MDGL is experiencing slight selling pressure.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $68.61
The current trend is moderately bullish and GILD is experiencing slight buying pressure.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.83 | Buy |
| Relative Strength Index (14 RSI): | 60.7 | Buy |
| Chaikin Money Flow: | -376014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (236.04 - 281.98) | Buy |
| Bollinger Bands (100): | (213.5 - 264.54) | Buy |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.93 | Buy |
| Relative Strength Index (14 RSI): | 57.58 | Buy |
| Chaikin Money Flow: | 1350154 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.34 - 68.22) | Buy |
| Bollinger Bands (100): | (65.43 - 73.03) | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 278.45 | Buy |
| 20-day SMA: | 266.97 | Buy |
| 50-day SMA: | 237.01 | Buy |
| 200-day SMA: | 212.46 | Buy |
| 8-day EMA: | 278.44 | Buy |
| 20-day EMA: | 267.14 | Buy |
| 50-day EMA: | 250.28 | Buy |
| 200-day EMA: | 226.23 | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.67 | Sell |
| 20-day SMA: | 66.05 | Buy |
| 50-day SMA: | 66.06 | Buy |
| 200-day SMA: | 73.91 | Sell |
| 8-day EMA: | 68.37 | Buy |
| 20-day EMA: | 67.06 | Buy |
| 50-day EMA: | 67.19 | Buy |
| 200-day EMA: | 72.14 | Sell |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.29 per share, an increase next quarter of $1.43 per share, a decrease this year of $8.67 per share, and an increase next year of $10.24 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.02 per share, a decrease this year of $3.03 per share, and an increase next year of $3.45 per share.
Madrigal Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||